In a mechanism of action study that aimed to achieve 10% body weight reduction in participants with obesity who were without T2D, tirzepatide was compared to placebo for sleeping and 24-h energy expenditure and respiratory exchange ratio by utilizing metabolic chambers assessed at baseline and after 18 weeks [56]
Clinical Trials and FDA Approval: Wegovy received FDA approval based on the impressive outcomes of the STEP clinical trials
Routine cost or convenience doesnt qualify
[7] [8] The drop in appetite also usually means less food and far less fiber, compounding the problem
It is not for human consumption, animal consumption, veterinary use, diagnostic use, cosmetic use, therapeutic applications, or medical treatment
Alternatively, your medical provider may increase the period in between injections